(Q47675424)
Statements
Cost-effectiveness analysis of trastuzumab (herceptin) in HER2-overexpressed metastatic breast cancer (English)
Jean-Paul Moatti
Carole Perez-Ellis
Anthony Goncalves
Jocelyne Jacquemier
Michel Marty
Véronique Girre
Henri Roché
Etienne Brain